top of page

Atara's Pascal Touchon on allo

Atara Biotherapeutics' CEO Pascal Touchon discusses his company's approved allogeneic cell therapy, and the EBV theory of multiple sclerosis.



Comentarios


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page